Skip to main content
Medtronic plc logo

Medtronic plc — Investor Relations & Filings

Ticker · MDT ISIN · US58446C1036 LEI · D56MRZY2INAN94ZONZ37 US Manufacturing
Open in API
Filings indexed 1,143 across all filing types
Latest filing 2019-07-02 Capital/Financing Update
Country US United States of America
Listing US MDT

About Medtronic plc

https://www.medtronic.com/

Medtronic plc is a global healthcare technology company that develops, manufactures, and sells device-based medical therapies and solutions. The company's portfolio addresses more than 70 health conditions, primarily organized into four key areas: Cardiovascular, Medical Surgical, Neuroscience, and Diabetes. Its products range from pacemakers and neurovascular care devices to insulin pumps and systems for robotic-assisted surgery. Medtronic's technologies are designed to be used by healthcare systems, physicians, clinicians, and patients to alleviate pain, restore health, and extend life.

Recent filings

Filing Released Lang Actions
8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content details a material definitive agreement related to a notes offering, including issuance of various senior notes, underwriting agreements, and related financial arrangements. It includes detailed information about the debt issuance, terms, and related agreements. This is a typical capital/financing update rather than a full annual or quarterly report, audit report, or earnings release. The document is lengthy (15,000 characters) and contains substantive information about financing activities. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2019-07-02 English
PRIMARY DOCUMENT
Director's Dealing
2019-06-27 English
424B5
Capital/Financing Update Classification · 100% confidence The document is a detailed prospectus supplement and prospectus related to a debt securities offering by Medtronic Global Holdings S.C.A. It includes registration fee calculations, terms of various senior notes, underwriting details, risk factors, and legal disclaimers. The document is filed pursuant to Rule 424(b)(5) under the Securities Act of 1933, which is a typical filing for securities offerings. The content focuses on the issuance of new debt securities, their terms, pricing, and underwriting arrangements, which aligns with capital raising activities. There is no indication that this is a financial report, earnings release, or management discussion. It is not a proxy, voting result, or governance document. The document is not a report publication announcement but the actual offering document. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2019-06-27 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on the upsizing of a tender offer and related financing activities, including details about senior notes and tender offers. It includes a press release as an exhibit and discusses financing transactions and their expected impact on financial results. There are no full financial statements or comprehensive financial analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). The document is primarily an update on capital structure and financing activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (7883 characters) and detailed content support this classification with high confidence.
2019-06-25 English
FWP
Capital/Financing Update Classification · 95% confidence The document is titled 'Free Writing Prospectus' and is filed pursuant to Rule 433 under a Registration Statement number. It contains detailed pricing terms for various series of senior notes issued by Medtronic Global Holdings S.C.A., including coupon rates, maturity dates, redemption options, ISINs, and other bond issuance details. The document is a prospectus supplement or pricing term sheet related to a debt offering. It is not a financial report, earnings release, or management discussion. It is also not a regulatory filing in the sense of officer certifications or voting results. The content clearly relates to capital raising and financing activities, specifically the issuance of debt securities. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (over 14,000 characters), indicating it is the actual document, not just an announcement of a report. Confidence is high given the clear nature of the document as a pricing term sheet for bond issuance.
2019-06-25 English
424B3
Capital/Financing Update Classification · 100% confidence The document is a preliminary prospectus supplement filed pursuant to Rule 424(b)(3) related to a shelf registration statement for debt securities (senior notes) by Medtronic Global Holdings S.C.A. It contains detailed information about the terms of the offering, including maturity dates, interest payments, redemption options, underwriting details, risk factors, and legal disclaimers. The document is a formal offering document for capital raising through debt issuance, not a financial report, earnings release, or management discussion. It is not a report publication announcement but the actual offering document. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2019-06-25 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.